A new small-scale study by the Imperial College London in collaboration with the University of Copenhagen and University College Dublin might have just discovered an alternative to gastric bypass surgery. Gastric bypass is a procedure where the stomach is divided into a small upper pouch and a larger, lower “remnant” pouch and then the small intestine is rearranged to connect to both. It’s a pretty common and effective weight loss procedure for patients with a BMI over 40.
But the surgery is known to have many risks, such as abdominal pain, chronic nausea, vomiting and low blood sugar levels…
Could hormones be the key?
So, the researchers set out to investigate if a hormone treatment could promote weight loss and improve blood sugar levels in patients with diabetes and those at risk of becoming obese.
The treatment was developed based on previous research by Imperial College London, which found that three hormones which originate in the bowels, glucagon-like peptide-1 (GLP-1), oxyntomodulin and peptide, may be responsible for weight loss during gastric bypass surgery.
READ MORE: Running Is Your Best Bet If You’re Genetically Prone To Obesity, According To This New Study
The researchers wanted to see if combining these hormones into the injectable mixture – known as GOP – could mimic the high levels of the hormones seen after surgery in order to reduce appetite, increase weight loss and reduce high glucose levels.
The study
The study featured 26 obese patients who were either diabetic or prediabetic (a condition where blood glucose is too high but not high enough to be classified as diabetes). Fifteen of the 26 patients received the hormone treatment, while 11 were given a placebo. They also received healthy eating and weight loss advice from a dietician. The injections were slowly administered under the skin for 12 hours a day, one an hour before breakfast and the other after their last meal.
READ MORE: Can You Really Target Fat Loss o A Specific Area, Or That That Total B.S.?